NanoSight's unique nanoparticle tracking analysis systems have enabled more than 400 research teams around the world to better understand the behaviour of materials on the sub-micron scale. It delivers the world's most versatile and proven multi-parameter nanoparticle analysis in a single instrument by visualizing, measuring and characterizing virtually all nanoparticles. Particle size, concentration, aggregation and zeta potential can all be analyzed while a fluorescence mode provides speciation of labeled particles. NanoSight provides real time monitoring of the subtle changes in the characteristics of particle populations with all of these analyses uniquely confirmed by visual validation.
Jeremy Warren, CEO of NanoSight, commented: "The products we sell are unique, and we estimate we are currently only in single digits in terms of percentage of market penetration. The recognition of this prestigious award further underscores our self-belief in that we are being successful in delivering cutting edge technology solutions in fields which impact directly on the quality of life. Applications that enable the production of better, more consistent vaccines to showing the ability to measure events that detect cancerous diseases earlier than ever before give us a lot of confidence for the coming years of more growth."